^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    dronabinol (BX-1)

    i
    Other names: BX-1
    Associations

    News

    Trials
    Company:
    Bionorica
    Drug class:
    Cannabinoid receptor agonist
    Related drugs:
    Associations

    News

    Trials
    6ms
    Treating Nightmares in Posttraumatic Stress Disorder With Dronabinol (clinicaltrials.gov)
    P2, N=170, Completed, Charite University, Berlin, Germany | Active, not recruiting --> Completed | Trial completion date: Jun 2025 --> Jan 2025
    Trial completion • Trial completion date
    |
    dronabinol (BX-1)
    11ms
    DIsCOvER: Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer (clinicaltrials.gov)
    P3, N=109, Completed, Arbeitsgemeinschaft medikamentoese Tumortherapie | Active, not recruiting --> Completed
    Trial completion
    |
    dronabinol (BX-1)
    12ms
    Treating Nightmares in Posttraumatic Stress Disorder with Dronabinol (clinicaltrials.gov)
    P2, N=176, Active, not recruiting, Charite University, Berlin, Germany | Recruiting --> Active, not recruiting
    Enrollment closed
    |
    dronabinol (BX-1)
    almost2years
    DIsCOvER: Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer (clinicaltrials.gov)
    P3, N=109, Active, not recruiting, Arbeitsgemeinschaft medikamentoese Tumortherapie | Recruiting --> Active, not recruiting
    Enrollment closed • Metastases
    |
    dronabinol (BX-1)
    2years
    Treating Nightmares in Posttraumatic Stress Disorder With Dronabinol (clinicaltrials.gov)
    P2, N=176, Recruiting, Charite University, Berlin, Germany | Trial completion date: Jul 2023 --> May 2025 | Trial primary completion date: May 2023 --> Jan 2025
    Trial completion date • Trial primary completion date
    |
    dronabinol (BX-1)
    over2years
    Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer (clinicaltrials.gov)
    P3, N=104, Recruiting, Arbeitsgemeinschaft medikamentoese Tumortherapie | Trial completion date: Mar 2024 --> Sep 2024 | Trial primary completion date: Mar 2024 --> Sep 2024
    Trial completion date • Trial primary completion date • Metastases
    |
    dronabinol (BX-1)
    over2years
    Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer (clinicaltrials.gov)
    P3, N=104, Recruiting, Arbeitsgemeinschaft medikamentoese Tumortherapie | Trial completion date: Sep 2023 --> Mar 2024 | Trial primary completion date: Sep 2022 --> Mar 2024
    Trial completion date • Trial primary completion date • Metastases
    |
    dronabinol (BX-1)
    over4years
    Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer (clinicaltrials.gov)
    P3, N=104, Recruiting, Arbeitsgemeinschaft medikamentoese Tumortherapie | Trial completion date: Jun 2022 --> Sep 2023 | Trial primary completion date: Jun 2022 --> Sep 2022
    Clinical • Trial completion date • Trial primary completion date
    |
    CRP (C-reactive protein)
    |
    dronabinol (BX-1)